| Literature DB >> 33569410 |
Fei Yu1, Haibo Huang2,3, Qihui Yu2,3, Yuqing Ma1, Qi Zhang2,3,4, Bo Zhang1.
Abstract
BACKGROUND: Transthoracic echocardiography (TTE) is widely used in clinics to evaluate left ventricular hypertrophy (LVH). However, TTE is usually insufficient for the etiological diagnoses when morphological and functional features are nonspecific. With the booming of computer science and artificial intelligence (AI), previous literature has reported the application of radiomics based on cardiac magnetic resonance imaging, cardiac computed tomography and TTE in diagnosing several myocardial abnormalities, such as myocardial infarction, myocarditis, cardiac amyloidosis, and hypertrophic cardiomyopathy (HCM). In this study, we explored the possibility of using myocardial texture features in differentiating HCM, hypertensive heart disease (HHD) and uremic cardiomyopathy (UCM) based on echocardiography. To our knowledge, this was the first study to explore TTE myocardial texture analysis for multiple LVH etiology differentiation.Entities:
Keywords: Left ventricular hypertrophy (LVH); artificial intelligence (AI); echocardiography; myocardium; texture
Year: 2021 PMID: 33569410 PMCID: PMC7867873 DOI: 10.21037/atm-20-4891
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
Figure 1Flow chart of the enrollment procedure.
Figure 2Echocardiographic images of the apical four-chamber (A4ch) view and marking of the hypertrophied ventricular septum as region of interest (ROI). HHD, hypertensive heart disease; HCM, hypertrophic cardiomyopathy; UCM, uremic cardiomyopathy.
Patient characteristics and routine echocardiography
| Characteristics | HHD | HCM | UCM | One-way ANOVA | |
|---|---|---|---|---|---|
| F | P | ||||
| No. of cases | n=50 | n=50 | n=50 | ||
| Age (year) | 64.8±13.0 | 54.3±14.0 | 61.1±14.5 | 7.535 | 0.001 |
| Female | 7 (14%) | 13 (26%) | 11 (22%) | χ2=2.277 | 0.320 |
| Echocardiography | |||||
| IVS thickness (mm) | 13.1±0.9 | 19.9±4.1 | 13.4±1.4 | 110.736 | 0.000 |
| LVPW thickness (mm) | 10.1±1.5 | 10.7±2.6 | 11.1±1.7 | 3.302 | 0.040 |
| IVS/LVPW ratio | 1.32±0.19 | 1.95±0.56 | 1.32±0.19 | 58.597 | 0.000 |
| LVEDd (mm) | 47.4±4.3 | 44.6±5.2 | 51.0±6.8 | 16.590 | 0.000 |
| LVEF | 0.64±0.06 | 0.67±0.08 | 0.60±0.10 | 9.759 | 0.000 |
| E/e’ ratio | 14.8±5.1 (n=47) | 16.2±2.3 (n=45) | 17.4±5.7 (n=45) | 2.619 | 0.077 |
HHD, hypertensive heart disease; HCM, hypertrophic cardiomyopathy; UCM, uremic cardiomyopathy; IVS, interventricular septum; LVPW, left ventricular posterior wall; LVEDd, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; E, early peak velocity of trans-mitral LV filling; e’, diastolic early peak tissue velocity at the mitral annulus.
Myocardial texture features of HHD, HCM and UCM (mean ± Std)
| Features | HHD [1] | HCM [2] | UCM [3] | P value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 1, 2 | 2 | 1 | 1 | 2 | ||||
| EtHis | 7.25±0.30 | 7.08±0.23 | 7.27±0.32 | 0.001 | 0.040 | 0.002 | <0.001 | <0.001 | 0.427 | <0.001 |
| EtBrt | 0.99±0.00 | 1.00±0.00 | 0.99±0.01 | <0.001 | 0.027 | <0.001 | <0.001 | <0.001 | 0.011 | <0.001 |
| Std | 43.18±6.96 | 36.82±6.17 | 44.93±6.98 | <0.001 | 0.063 | <0.001 | <0.001 | <0.001 | 0.219 | <0.001 |
| CoV | 0.35±0.06 | 0.26±0.07 | 0.38±0.08 | <0.001 | 0.069 | <0.001 | <0.001 | <0.001 | 0.008 | <0.001 |
| Skew | 0.10±0.41 | 0.30±0.37 | 0.01±0.46 | 0.002 | 0.456 | 0.010 | 0.001 | 0.013 | 0.278 | 0.001 |
| Cont7 | 4.56±1.80 | 3.71±1.14 | 4.86±1.99 | 0.003 | 0.046 | 0.055 | <0.001 | 0.001 | 0.942 | 0.001 |
| E11 | 0.04±0.02 | 0.05±0.01 | 0.04±0.01 | 0.009 | 0.071 | 0.051 | <0.001 | 0.002 | 0.920 | 0.001 |
| Hm5 | 0.52±0.03 | 0.55±0.04 | 0.52±0.05 | 0.002 | 0.047 | 0.062 | 0.001 | 0.001 | 0.937 | 0.005 |
| Et3 | 4.93±0.32 | 4.77±0.33 | 4.93±0.29 | 0.012 | 0.085 | 0.145 | 0.002 | 0.009 | 0.762 | 0.010 |
HHD, hypertensive heart disease, is marked as “1” in P value columns; HCM, hypertrophic cardiomyopathy, is marked as “2” in P value columns; UCM, uremic cardiomyopathy, is marked as “3” in P value columns.
The AUCs of texture features
| Features | 1 | 1, 2 | 2 | 1 | 1 | 2 |
|---|---|---|---|---|---|---|
| EtHis | 0.60 | 0.66 | 0.76 | 0.74 | 0.55 | 0.77 |
| EtBrt | 0.61 | 0.77 | 0.87 | 0.86 | 0.65 | 0.88 |
| Std | 0.60 | 0.69 | 0.78 | 0.76 | 0.57 | 0.81 |
| CoV | 0.60 | 0.77 | 0.87 | 0.85 | 0.66 | 0.89 |
| Skew | 0.55 | 0.63 | 0.68 | 0.66 | 0.56 | 0.70 |
| Cont7 | 0.60 | 0.60 | 0.70 | 0.70 | 0.50 | 0.69 |
| E11 | 0.59 | 0.60 | 0.69 | 0.68 | 0.49 | 0.69 |
| Hm5 | 0.60 | 0.58 | 0.68 | 0.69 | 0.50 | 0.66 |
| Et3 | 0.59 | 0.57 | 0.65 | 0.65 | 0.52 | 0.66 |
The three groups are marked as “1”, “2” and “3” for short in the table. Group 1 stands for hypertensive heart disease, group 2 for hypertrophic cardiomyopathy, and group 3 for uremic cardiomyopathy. AUC, areas under the receiver operating characteristic curve.
Interobserver and intraobserver variability of texture features
| Features | Interobserver ICC | Intraobservoer ICC |
|---|---|---|
| EtHis | 0.249 | 0.269 |
| EtBrt | 0.734 | 0.707 |
| Std | 0.755 | 0.693 |
| CoV | 0.748 | 0.794 |
| Skew | 0.833 | 0.847 |
| Cont7 | 0.594 | 0.544 |
| E11 | 0.444 | 0.468 |
| Hm5 | 0.613 | 0.743 |
| Et3 | 0.417 | 0.659 |
ICC, intraclass correlation coefficient.
Classification results by support vector machine using EtBrt, Std and CoV
| Classification between groups | Acc | Sen | Spc | YI | AUC |
|---|---|---|---|---|---|
| 1 | 0.68 | 0.59 | 0.78 | 0.37 | 0.70 |
| 1, 2 | 0.68 | 0.77 | 0.76 | 0.42 | 0.75 |
| 2 | 0.78 | 0.84 | 0.75 | 0.59 | 0.87 |
| 1 | 0.85 | 0.90 | 0.80 | 0.70 | 0.91 |
| 1 | 0.67 | 0.56 | 0.76 | 0.32 | 0.68 |
| 2 | 0.85 | 0.78 | 0.91 | 0.68 | 0.86 |
The three groups are marked as “1”, “2” and “3” for short in the table. Group 1 stands for hypertensive heart disease, group 2 for hypertrophic cardiomyopathy, and group 3 for uremic cardiomyopathy. Sen, sensitivity; Spc, specificity; Acc, accuracy; YI, Youden index; AUC, area under the receiver operating characteristic curve.